Waters Corporation (NYSE: WAT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Onclarity HPV ...

The life sciences and diagnostics company said Wednesday the regulator cleared its Onclarity HPV Self-Collection Kit and approved the BD Onclarity HPV Assay with extended genotyping for at-home use.

Waters Corporation (WAT) stock gains as the FDA clears the company's Onclarity HPV self-collection kit for use with BD’s (BDX ...

Waters Corporation WAT shares are up on Wednesday as the company announced FDA clearance for its Onclarity HPV ...

The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer. Kinase drug discovery programs rely on the precise characterization and screening of ...

Canopy Biosciences, a Bruker Company, today announced the launch of a first in a series of assay kits for ChipCytometry TM, a quantitative, high dynamic range (HDR) and high-resolution multiplexing ...

Biotium, a leading developer of fluorescent reagents for life science research, announces the launch of the RNaseReveal™ Activity Assay Kit, with unparalleled sensitivity to detect RNase contamination ...

MALVERN, Pa.--(BUSINESS WIRE)--LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools and protein microarrays, announced today ...

Molecular Devices, at SLAS 2015, launched a homogeneous, no-wash assay to measure ligand- and voltage-gated potassium channel activity. The FLIPR® Potassium Assay Kit uses a novel thallium-sensitive ...

Managing drug dosage is critical to the overall success of pharmaceutical intervention, not only in the clinic but also in clinical trials. Inadequate dose management of certain drugs can have fatal ...

FDA-approved BD Onclarity HPV Assay is the most comprehensive screening tool for HPV in the U.S.1,4 with extended genotyping and end-to-end automated lab workflows. At-home self-collection ...